Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions

NEXT STORY
Mind the Graph announces the world’s first AI-powered Poster Maker for Scientists
PREV STORY
Simply Better Brands Corp. Announces Second Quarter 2021 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics Receives Approval in Europe to Resume Patient Accrual for Phase 3 Tedopi® Clinical Trial in Advanced Non-Small Cell Lung Cancer Patients Following Immune Checkpoint Inhibitor Treatment

Phase 3 Trial received Approval to be Initiated in Israel Patient Accrual Already Resumed ...

author_avatar
NASDAQ Market News

Toronto General Hospital Physicians Presented Interim Clinical Study Results for MR-guided FLA Treatment of Low-intermediate Risk Localized Prostate Cancer at AdMeTech 4th Global Summit

author_avatar
NASDAQ Market News

Galena Biopharma to Present at the Sachs Associates 16th Annual Biotech in Europe Forum

SAN RAMON, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News